APA aipamena

Li, W., Li, D., Chen, K., Chen, Z., Zong, Y., Yin, H., . . . Tao, M. (2012). Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the α-fetoprotein promoter enhancer and pgk promoter: An in vitro and in vivo study. BioMed Central.

Chicago Style aipamena

Li, Wei, et al. Development of a Gene Therapy Strategy to Target Hepatocellular Carcinoma Based Inhibition of Protein Phosphatase 2A Using the α-fetoprotein Promoter Enhancer and Pgk Promoter: An in Vitro and in Vivo Study. BioMed Central, 2012.

MLA aipamena

Li, Wei, et al. Development of a Gene Therapy Strategy to Target Hepatocellular Carcinoma Based Inhibition of Protein Phosphatase 2A Using the α-fetoprotein Promoter Enhancer and Pgk Promoter: An in Vitro and in Vivo Study. BioMed Central, 2012.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.